Genex Pharmaceutical Inc GENX:Over The Counter Mkt

*Data is delayed | Exchange | USD
Last | 09/15/23 EDT
0.0001UNCH (UNCH)
52 week range
0.00 - 0.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0001
  • 52 Week High0.00
  • 52 Week High Date09/15/23
  • 52 Week Low0.00
  • 52 Week Low Date09/15/23

Key Stats

  • Market Cap321.223
  • Shares Out3.21M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-2.87
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0001
  • 52 Week High0.00
  • 52 Week High Date09/15/23
  • 52 Week Low0.00
  • 52 Week Low Date09/15/23
  • Market Cap321.223
  • Shares Out3.21M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-2.87
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)522,130.013
  • ROE (TTM)7.77%
  • Revenue (TTM)3.237M
  • Gross Margin (TTM)88.75%
  • Net Margin (TTM)10.58%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Genex Pharmaceutical Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Genex Pharmaceutical, Inc. (Genex) was considered a development-stage company prior to June 17, 2004. Genex was a start-up, Internet-based fulfillment company with offices in Vancouver, British Columbia, Canada. On June 8, 2004, Genex entered into a share purchase agreement with Tianjin Zhongjin Biology Development Co., Ltd. (Zhongjin). On June 17, 2004, the stock purchase made pursuant to the share purchase agreement was consummated and Zhongjin became a wholly owned...
Song Fuzhi
Chairman of the Board, President, Chief Executive Officer
Zhang Shuli
Chief Financial Officer, Treasurer
Address
1801 Guangyin Building
Youyibeilu, Hexi District
Tianjin, TNJ
300074
China